US court upholds Forest Lexapro patent, shrs jump (Reuters via Yahoo! Asia News)

US court upholds Forest Lexapro patent, shrs jump (Reuters via Yahoo! Asia News)
LOS ANGELES, July 13 (Reuters) – Forest Laboratories Inc. said on Thursday that a Delaware U.S. District Court has ruled that its patent on the active ingredient in its anti-depressant drug Lexapro is valid, enforceable and infringed by proposed generic competition.